Regen BioPharma Inc Quarterly Common Stock, Shares, Issued from Q3 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Regen BioPharma Inc quarterly Common Stock, Shares, Issued history and growth rate from Q3 2013 to Q3 2024.
  • Regen BioPharma Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 5.26M shares, a 50% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.26M +1.75M +50% Sep 30, 2024 8-K 2024-11-29
Q2 2024 4.37M Jun 30, 2024 10-Q 2024-08-13
Q4 2023 3.75M Dec 31, 2023 10-Q 2024-01-19
Q3 2023 3.51M +152K +4.52% Sep 30, 2023 8-K 2024-11-29
Q3 2022 3.35M -4.35B -99.9% Sep 30, 2022 10-K 2023-11-20
Q1 2022 4.58B +1.65B +56.1% Mar 31, 2022 10-Q 2022-04-21
Q4 2021 4.56B +2.3B +102% Dec 31, 2021 10-Q 2022-01-20
Q3 2021 4.35B +2.75B +171% Sep 30, 2021 10-K 2022-11-15
Q2 2021 3.78B +2.18B +136% Jun 30, 2021 10-Q/A 2021-12-22
Q1 2021 2.93B +2.77B +1728% Mar 31, 2021 10-Q 2021-08-18
Q4 2020 2.26B +838M +58.9% Dec 31, 2020 10-Q 2021-08-13
Q3 2020 1.61B +1B +167% Sep 30, 2020 10-K 2021-12-22
Q2 2020 1.61B +1.09B +210% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 161M -217M -57.4% Mar 31, 2020 10-Q 2021-08-05
Q4 2019 1.42B +1.17B +464% Dec 31, 2019 10-Q 2021-08-05
Q3 2019 600M +420M +233% Sep 30, 2019 10-Q 2021-08-05
Q2 2019 518M +360M +227% Jun 30, 2019 10-Q 2019-10-24
Q1 2019 377M +226M +149% Mar 31, 2019 10-Q 2019-08-29
Q4 2018 252M +106M +72.4% Dec 31, 2018 10-Q 2019-02-12
Q3 2018 180M +40.6M +29.1% Sep 30, 2018 10-K 2021-06-21
Q2 2018 159M +20.6M +14.9% Jun 30, 2018 10-Q 2018-08-06
Q1 2018 151M +13.2M +9.57% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 146M +145M +14518% Dec 31, 2017 10-Q 2018-02-06
Q3 2017 140M -8.45K -0.01% Sep 30, 2017 10-K 2018-12-27
Q2 2017 138M +3.56M +2.65% Jun 30, 2017 10-Q 2017-08-07
Q1 2017 138M +9.86M +7.69% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 1M -123M -99.2% Jan 5, 2017 10-K 2018-01-05
Q3 2016 140M +25M +21.8% Sep 30, 2016 10-Q 2017-01-27
Q2 2016 135M +21M +18.5% Jun 30, 2016 10-Q/A 2017-04-28
Q1 2016 128M +18.9M +17.3% Mar 31, 2016 10-Q/A 2017-04-28
Q4 2015 124M +72.2M +139% Dec 31, 2015 10-Q/A 2017-04-28
Q3 2015 115M +63.1M +122% Sep 30, 2015 10-Q/A 2017-04-28
Q2 2015 114M +61.6M +119% Jun 30, 2015 10-Q/A 2017-04-28
Q1 2015 109M +57.4M +111% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 52M Dec 31, 2014 10-Q 2015-02-04
Q3 2014 51.6M 0 0% Sep 30, 2014 10-K/A 2017-04-28
Q2 2014 51.9M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 51.9M Mar 31, 2014 10-Q 2014-05-05
Q3 2013 51.6M Sep 30, 2013 10-K 2014-12-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.